CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call Transcript April 24, 2024 CureVac N.V. isn’t one of the 30 most popular stocks among hedge funds at the ...
Business Insider4h
Pfizer's Beqvez Receives FDA Approval For Treatment Of Adults With Hemophilia B
(RTTNews) - Friday, Pfizer Inc. (PFE) announced that its gene therapy Beqvez also known as fidanacogene elaparvovec-dzkt has been approved by the FDA for treating adults with moderate to severe ...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...
The Valdosta Daily Times1h
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
(NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who ...